REFERENCES
- Advenier C., Queille-Roussel C. Rational use of antihistamines in allergic dermatological conditions, Drugs. 1989; 38: 634–644
- Theoharides T. C. Histamine (H2)–receptor antagonists in the treatment of urticaria, Drugs. 1989; 37: 345–355
- Yamane M. A., Williams A. C., Barry B. W. Terpene penetration enhancers in propylene glycol/water co-solvent system: effectiveness and mechanism of action. J. Pharm. Pharmacol 1995; 47: 978–989
- Rieg-Falson F. Taking advantage of the excipient skin partnership to modify percutaneous absorption. B. T. Gattefosser 1991; 84: 17–23
- Ritschel W. A., Hussain A. S. Influence of selected solvents on penetration of griseofulvin in rat skin, in vitro. Pharm. Ind. 1988; 50: 483–486
- Potts R. O., Golden G. M., Francoer M. L., Mak V. H. W., Guy R. H. Mechanism and enhancement of solute transport across the stratum corneum. J. Controlled Release 1991; 15: 249–260
- Friend D. R. In vitro skin permeation techniques. J. Controlled Release 1992; 18: 235–248
- Franz T. J. Percutaneous absorption. On the relevance of in vitro data. J. Invest. Dermatol 1975; 64: 190–196
- Williams A. C., Barry B. W. The enhancement index concept applied to terpene penetration enhancers for human skin and model lipophilic (estradiol) and hydrophilic (5-fluorouracile) drugs. Int. J. Pharm 1991; 74: 157–168
- Babar A., Solanki U. D., Cutie A. J, Plakogiannis F. Piroxicam release from dermatological bases: in vitro studies using cellulose membrane and hairless mouse skin. Drug Dev. Ind. Pharm. 1990; 16: 523–540